No Data
No Data
No Data
No Data
No Data
Qualigen Announced An Agreement With Marizyme To Commercialize DuraGraft
RTTNewsApr 16 20:23
Marizyme Announces Director Julie Kampf's Resignation
TipRanksFeb 7 17:21
Marizyme Inc CEO Releases Corporate Update Including Details of Key Progress on DuraGraft
Yahoo FinanceOct 31, 2023 03:23
InvestmentPitch Media Video Features Marizyme's CEO David Barthel Discussing Receipt of FDA Clearance for Its Flagship DuraGraft Medical Device
VANCOUVER, BC / ACCESSWIRE / October 13, 2023 / Marizyme, Inc. (OTCQB:MRZM), a global multi-technology biomedical company dedicated to the accelerated development and commercialization of medical tech
AccesswireOct 13, 2023 18:00
The Watchlist by The Market Herald Releases New Interviews With Marizyme, Regenx, BuildDirect, and Three Sixty Solar Discussing Their Latest News
VANCOUVER, BC / ACCESSWIRE / October 6, 2023 / The Watchlist by The Market Herald has announced the release of new interviews with FPX Nickel, Pelangio Exploration, Nicola Mining, and Max Resource dis
AccesswireOct 7, 2023 04:00
Marizyme, Inc. Announces FDA Clearance for Flagship Product, DuraGraft
DuraGraft is the first and only FDA cleared medical device for use as an intra-operative vascular conduit storage and flushing solution used during CABG surgeries JUPITER, FL, Oct. 06, 2023 (GLOBE NEWSWIRE) -- via
GlobeNewswireOct 6, 2023 21:00
No Data
No Data